Sinocare(300298.SZ)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Sinocare
300298.SZ
Sinocare Inc. engages in the development, manufacture, and marketing of rapid diagnosis testing products primarily in the People’s Republic of China. It offers blood glucose and pressure monitors; point of care testing products; digital management tool solutions; non-invasive screening products; and PTS and Trividia products. The company provides its products for the patients with chronic diseases and diabetes, as well as for healthcare professionals.
871.65 B
300298.SZMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
B
Health Care EquipmentIndustry
Industry Ranking14/64
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.62%C
    • Profit Margin2.43%C
    • Gross Margin52.51%B
  • Growth ScoreC
    • Revenue YoY8.63%B
    • Net Profit YoY-62.76%D
    • Total Assets YoY-3.38%D
    • Net Assets YoY-11.16%E
  • Cash ScoreB
    • Cash Flow Margin384.00%A
    • OCF YoY8.63%B
  • Operating ScoreB
    • Turnover0.82B
  • Debt ScoreC
    • Gearing Ratio40.94%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Sinocare Showcases Digital Innovation at the 93rd CMEF, Advancing Global Chronic Disease Management

    Unusual Whales·
    SZ
    300298
    -1.24%
    Unusual Whales·
    SZ
    300298
    -1.24%

    Sinocare: Plans to repurchase shares worth RMB 150 million to 300 million, with the repurchase price not exceeding RMB 25 per share

    Wallstreetcn·
    SZ
    300298
    -1.24%
    Wallstreetcn·
    SZ
    300298
    -1.24%

    00:57 ETATTD Spotlight: Von Blutzuckerwerten zu KI-basierten Erkenntnissen - eine neue Richtung für das Diabetes-Management

    prnewswire·
    SH
    520880
    -1.12%
    SZ
    159883
    -1.27%
    US
    IHF
    -0.41%
    prnewswire·
    SH
    520880
    -1.12%
    SZ
    159883
    -1.27%
    US
    IHF
    -0.41%

    Sinocare has repurchased 1.22% of its shares, costing 139 million yuan

    Zhitong·
    SZ
    300298
    -1.24%
    Zhitong·
    SZ
    300298
    -1.24%

    Sinocare released its performance for the first three quarters, with a net profit attributable to the parent company of 211 million yuan, a decrease of 17.36%

    Zhitong·
    SZ
    300298
    -1.24%
    Zhitong·
    SZ
    300298
    -1.24%
    © 2026 Longbridge｜Disclaimer